GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (TSX:APLI) » Definitions » Interest Income

Appili Therapeutics (TSX:APLI) Interest Income : C$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Appili Therapeutics Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Appili Therapeutics's interest income for the three months ended in Dec. 2024 was C$0.00 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

Appili Therapeutics Interest Income Historical Data

The historical data trend for Appili Therapeutics's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Interest Income Chart

Appili Therapeutics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Income
Get a 7-Day Free Trial 0.04 0.12 0.03 0.03 0.02

Appili Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - - - -

Appili Therapeutics Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Appili Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (TSX:APLI) » Definitions » Interest Income
Comparable Companies
XCNQ:NURL XCNQ:MYND TSXV:MRVL TSXV:RKV XCNQ:AGN XCNQ:ASEP TSXV:XRTX XCNQ:ENBI XCNQ:HEAL XCNQ:LOBE VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
APLIF:USA
Address
1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8
Website
https://www.appilitherapeutics.com
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.
Executives
Donald Cilla Director
The K2 Principal Fund L.p. 10% Security Holder

Appili Therapeutics Headlines

No Headlines